Phase III, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Multicenter Study toEvaluate the Efficacy for (Induction of Remission) and Safety of Etrolizumab Compared with Placebo inPatients with Moderate to Severe Ulcerative Coliti

Project: Research project

Project Details

Description

Phase III, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy for (Induction of Remission) and Safety of Etrolizumab Compared with Placebo in Patients with Moderate to Severe Ulcerative Coliti
StatusActive
Effective start/end date1/1/1912/31/21

Funding

  • Genentech Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.